System for delivery of a fiducial marker
A transurethral system for delivering and depositing fiducial markers usable to delineate the prostate during radiation therapy includes at least one implant or anchor assembly featuring a first anchoring component, a second anchoring component, and a connector. A delivery device featuring a handle assembly, an actuator, and an elongate member delivers the implant or anchor assembly to an interventional site.
1. A system for delivering and depositing at least one fiducial marker to tissue at an interventional site within a body of a human patient, comprising:
an anchor assembly deployable at the interventional site, the anchor assembly comprising a first anchoring component, a second anchoring component, a connector, and the at least one fiducial marker, wherein:
the at least one fiducial marker comprises a sheet of a radiopaque material that forms an interference fit between at least one of the first anchoring component or the second anchoring component and the connector; and
a fiducial delivery device carrying the anchor assembly, the fiducial delivery device comprising:
an elongate member to be inserted into the body of the human patient and advanced to the interventional site; and
an actuator usable to deploy the anchor assembly at the interventional site.
2. The system of claim 1 , further comprising a second anchor assembly, the second anchor assembly including a third anchoring component and a fourth anchoring component, and at least one second fiducial marker made of the radiopaque material attached to at least one of the third anchoring component or the fourth anchoring component.
3. The system of claim 2 , wherein the second anchor assembly includes three fiducial markers attached to at least one of the third anchoring component or the fourth anchoring component.
4. The system of claim 1 , wherein the at least one fiducial marker is attached to the connector by sandwiching the sheet between the connector and one of the first anchoring component or the second anchoring component.
5. The system of claim 4 , further comprising a second anchor assembly, the second anchor assembly including a connector with three fiducial markers attached to the connector.
6. The system of claim 1 , wherein the at least one fiducial marker is attached to one of the first anchoring component or the second anchoring component by sandwiching the sheet between the connector and one of the first anchoring component or the second anchoring component.
7. The system of claim 6 , further comprising a second anchor assembly, the second anchor assembly including a third anchoring component, a fourth anchoring component, and at least one second fiducial marker, wherein the at least one second fiducial marker comprises three fiducial markers attached to at least one of the third anchoring component or the fourth anchoring component.
8. The system of claim 1 , further comprising a second anchor assembly, the second anchor assembly including a third anchoring component and a fourth anchoring component, and at least one second fiducial marker wherein a radiopaque material of the at least one second fiducial marker is a dye or a contrast agent.
9. The system of claim 8 , further comprising a second connector disposed between the third anchoring component and the fourth anchoring component, wherein the dye or the contrast agent coats a length of the second connector.
10. The system of claim 9 , wherein the third anchoring component and/or the fourth anchoring component further comprises a reservoir to hold the dye or the contrast agent.
11. The system of claim 1 , further comprising a second anchor assembly, the second anchor assembly including a third anchoring component, a fourth anchoring component, a second connector, and at least one second fiducial marker wherein the second connector includes a rounded tip configured to extend into an extra-prostatic space when the second anchor assembly is implanted into a prostatic lobe of the human patient, wherein the rounded tip includes radiopaque material and serves as the at least one second fiducial marker.
12. The system of claim 1 , wherein the fiducial delivery device further comprises a needle advanceable from the elongate member.
13. The system of claim 12 , wherein the needle is configured to deliver the at least one fiducial marker.
14. The system of claim 12 , further comprising at least one second fiducial marker, wherein the at least one second fiducial marker comprises a dye or contrast agent delivered by the needle.
15. The system of claim 1 , wherein the at least one fiducial marker is configured to be placed in intra-prostatic space, extra-prostatic space, on a prostatic capsule, or combinations thereof.
16. The system of claim 1 , further comprising a second anchor assembly, the second anchor assembly including at least one second fiducial marker, wherein the at least one second fiducial marker is biodegradable.
17. The system of claim 1 , further comprising a second anchor assembly, the second anchor assembly including at least one second fiducial marker, wherein the at least one second fiducial marker delivers therapy to tissue.
18. The system of claim 1 , further comprising a second anchor assembly, the second anchor assembly including at least one second fiducial marker configured to be delivered to span a gland or organ.
19. The system of claim 1 , further comprising a second anchor assembly, the second anchor assembly including at least one second fiducial marker, wherein the at least one second fiducial marker is configured to be placed at a tissue plane.